5653-51-0

Basic information

• Product Name: Benzoic acid, 6-amino-2,3-dimethoxy-
• CAS NO: 5653-51-0
• Molecular Formula: C9H11NO4
• Molecular Weight: 197.191
• Mol File: 5653-51-0.mol

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 6-amino-2,3-dimethoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 6-amino-2,3-dimethoxy-(5653-51-0)
• EPA Substance Registry System: Benzoic acid, 6-amino-2,3-dimethoxy-(5653-51-0)

Safety Data

• Hazardous Substances Data: 5653-51-0(Hazardous Substances Data)

Upstream product

• 4667-74-7 3,4-dimethoxyphthalimide 
• 86-51-1 2,3-dimethyoxybenzaldehyde 
• 106107-48-6 6-((tert-butoxycarbonyl)amino)-2,3-dimethoxybenzoic acid 
• 102421-43-2 N-((1,1-dimethylethyl)oxycarbonyl)-3,4-dimethoxyaniline 
• 6315-89-5 3,4-dimethoxyaniline 
• 124-38-9 carbon dioxide 
• 72517-26-1 2,3-dimethoxy-6-nitrobenzoic acid 

Downstream Products

• 128823-83-6 methyl 6-amino-2,3-dimethoxybenzoate 
• 81595-20-2 2-(dimethylamino)-5,6-dimethoxy-4(1H)-quinazolinone 
• 81595-28-0 2-(dimethylamino)-5,6-dihydroxy-3,4-dihydroquinazoline hydrobromide 
• 1191076-37-5 C₉H₉N₃O₄ 
• 1429439-90-6 1-ethyl-5-hydroxy-6-((4-methoxybenzyl)oxy)-4-oxo-1,4-dihydroquinolin-3-carboxylic acid 
• 1429439-91-7 1-ethyl-5-hydroxy-6-((4-methoxybenzyl)oxy)-4-oxo-N-(2-(pyrrolidin-1-yl)ethyl)-1,4-dihydroquinolin-3-carboxamide 
• 1429439-89-3 ethyl 1-ethyl-5-hydroxy-6-((4-methoxybenzyl)oxy)-4-oxo-1,4-dihydroquinolin-3-carboxylate 
• 854872-65-4 6-benzyloxy-2,3-dimethoxy-benzoic acid 
• 854869-15-1 6-benzyloxy-2,3-dimethoxy-benzoyl chloride 
• 873978-84-8 1-(6-benzyloxy-2,3-dimethoxy-phenyl)-ethanone 
• 85395-95-5 5-hydroxy-6-methoxy-2-phenyl-4H-chromen-4-one 
• 854660-46-1 6-carboxymethylsulfanyl-2,3-dimethoxy-benzoic acid 
• 854660-40-5 6-mercapto-2,3-dimethoxy-benzoic acid 
• 106107-49-7 ethyl 2-carboxy-3,4-dimethoxybenzenecarbamate 

Relevant articles and documents

ANTIBACTERIAL COMPOUNDS

The present Invention relates to cephalosporin antibacterial compounds of Formula (!): corresponding pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions, compound preparation and treatment methods for bacterial infections, especially those caused by gram-negative bacteria.

NEW DS DNA BINDING FLUORESCENT DYES

The present invention is directed to a fluorescent dye comprising a benzothiazolium moiety and a pyrimidinium moiety connected by a mono-methine bridge, characterized in that (i) the 2-position of the pyrimidine carries a substituent which starts with a C

FUSED-RING PYRIMIDIN-4(3H)-ONE DERIVATIVES, PROCESSES FOR THE PREPARATION AND USES THEREOF

AbstractNovel compounds of the following formula (I) and pharmacologically acceptable salt and esters thereof can modulate LXR function and as a result show excellent anti-arteriosclerotic and anti-inflammatory activity:wherein:A represents aryl or heteroaryl;R1, R2 and R3 are the same or different and each represents hydrogen, hydroxyl, nitro, cyano, amino, halogen, carboxy, carbamoyl, mercapto, alkyl, haloalkyl, alkylcarbonyloxy, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, dialkylamino, alkylcarbonylamino, N-(alkylcarbonyl)-N-(alkyl)amino, alkoxycarbonylamino, N-(alkoxycarbonyl)-N-(alkyl)amino, alkylsulfonylamino, N-(alkylsulfonyl)-N-(alkyl)amino, haloalkylsulfonylamino, N-(haloalkylsulfonyl)-N-(alkyl)amino, alkylcarbonyl, alkoxycarbonyl, alkylaminocarbonyl or dialkylaminocarbonyl group, or R1 and R2 together are alkylenedioxy;R4 and R5 are the same or different and each represents hydrogen, hydroxyl, amino, halogen, mercapto, alkyl, haloalkyl, alkoxy, alkoxycarbonyl or alkylthio;X represents hydrogen, hydroxyl, halogen, alkoxy or haloalkoxy; andY represents an optionally substituted alkyl, cycloalkyl, heterocyclyl, aryl, cycloalkylalkyl, heterocyclylalkyl or aralkyl group.

Substituted quinazolinediones

The synthesis of 5,6-dioxy substituted quinazolinediones is described. The novel quinazolinediones are useful as cardiotonic agents.

Substituted 5,6-dialkoxyquinazoline derivatives

Quinazoline derivatives having an oxy substituent in 5 and 6 positions are described. The novel quinazoline derivatives are useful as cardiotonic agents.

Process for the preparation of 5,6-dialkoxyanthranilic acids

A process for the preparation of 5,6-dialkoxyanthranilic acids is described. The 5,6-dialkoxyanthranilic acids are useful in the preparation of substituted quinazolinediones which are active cardiotonic agents.

A Regioselective Entry to 13-Substituted 8-Oxoprotoberberines. Total Synthesis of (+/-)-Corydaline

13-Alkyl and 13-aryl substituted 8-oxoprotoberberines were obtained by interamolecular benzyne cycloaddition of isoquinolinopyrrolinediones with arynes.This convergent and highly regioselective reaction has been applied to the synthesis of (+/-)-corydalin

Synthesis of 2-(Alkylamino)-5,6- and -6,7-dihydroxy-3,4-dihydroquinazolines and Evaluation as Potential Dopamine Agonists

Based upon the known dopaminergic properties of 2-aminodihydroxy-1,2,3,4-tetrahydronaphthalenes (ADTN's), heterocyclic congengers were prepared.Several 2-(alkylamino)-5,6- and -6,7-dihydroxy-3,4-dihydroquinazolines were synthesized and tested for a dopami